ID: ALA4164902

Max Phase: Preclinical

Molecular Formula: C26H32N2O2

Molecular Weight: 404.55

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCOc1ccc(-c2cn(CCN3CCCCCC3)c3ccccc3c2=O)cc1

Standard InChI:  InChI=1S/C26H32N2O2/c1-2-19-30-22-13-11-21(12-14-22)24-20-28(18-17-27-15-7-3-4-8-16-27)25-10-6-5-9-23(25)26(24)29/h5-6,9-14,20H,2-4,7-8,15-19H2,1H3

Standard InChI Key:  VVJDLXXKAPAQQP-UHFFFAOYSA-N

Associated Targets(Human)

Macrophage cell line 190 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mycobacterium avium 4587 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mycolicibacterium smegmatis 8003 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 404.55Molecular Weight (Monoisotopic): 404.2464AlogP: 5.33#Rotatable Bonds: 7
Polar Surface Area: 34.47Molecular Species: BASEHBA: 4HBD: 0
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.35CX LogP: 5.49CX LogD: 3.55
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.53Np Likeness Score: -0.88

References

1. Cannalire R, Machado D, Felicetti T, Santos Costa S, Massari S, Manfroni G, Barreca ML, Tabarrini O, Couto I, Viveiros M, Sabatini S, Cecchetti V..  (2017)  Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.,  140  [PMID:28964936] [10.1016/j.ejmech.2017.09.014]

Source